Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adiponectin, structure, function and pathophysiological implications in non-alcoholic fatty liver disease.

N Méndez-Sánchez1, N C Chavez-Tapia, D Zamora-Valdés

  • 1Liver Unit and Biomedical Research Department, Medica Sur Clinic and Foundation, Mexico City, Mexico. nmendez@medicasur.org.mx

Mini Reviews in Medicinal Chemistry
|June 22, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automatic Pipeline for Kinematic Tracking of Clinically Relevant Upper-Limb Motor Tasks in Humans and Macaque.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Factor XI/XIa inhibitors for splanchnic vein thrombosis associated with liver cirrhosis: Is there any potential role?

Revista de gastroenterologia de Mexico (English)·2025
Same author

Periprocedural and perioperative anticoagulation management strategies in liver cirrhosis.

Revista de gastroenterologia de Mexico (English)·2025
Same author

Extended left hepatectomy for massive intrahepatic cholangiocarcinoma in a patient with congenital malformation of the inferior vena cava.

Revista de gastroenterologia de Mexico (English)·2025
Same author

Splenic tear due to ERCP: A case report and literature review.

Revista de gastroenterologia de Mexico (English)·2025
Same author

Evidence gaps in orthognathic surgery: an international Delphi study.

International journal of oral and maxillofacial surgery·2024

Adiponectin, a hormone from fat cells, is decreased in obesity and insulin resistance. Lower adiponectin levels are linked to metabolic syndrome, impacting insulin resistance and fatty liver disease treatment.

Area of Science:

  • Endocrinology
  • Metabolic Syndrome Research
  • Adipose Tissue Biology

Background:

  • Obesity is a primary risk factor for metabolic syndrome, encompassing insulin resistance, type 2 diabetes, dyslipidemia, hypertension, and atherosclerosis.
  • Adipose tissue functions as an endocrine organ, secreting hormones that regulate metabolism, appetite, and energy expenditure.
  • Adiponectin, a hormone exclusively produced by adipocytes, plays a crucial role in metabolic regulation and is implicated in insulin resistance and atherosclerosis.

Purpose of the Study:

  • To review the chemistry and physiology of adiponectin.
  • To discuss the role of adiponectin in the pathophysiology of insulin resistance and non-alcoholic fatty liver disease.
  • To explore potential therapeutic strategies targeting adiponectin for metabolic disorders.

Main Methods:

Related Experiment Videos

  • Literature review of existing research on adiponectin.
  • Synthesis of current knowledge on adiponectin's structure and function.
  • Analysis of studies investigating adiponectin's involvement in metabolic diseases.

Main Results:

  • Adiponectin levels are paradoxically decreased in individuals with insulin resistance and obesity.
  • Reduced adiponectin is associated with increased risk of metabolic syndrome components, including atherosclerosis and non-alcoholic fatty liver disease.
  • Adiponectin's unique regulatory mechanisms offer potential therapeutic targets.

Conclusions:

  • Adiponectin is a key hormone linking obesity to metabolic dysfunction.
  • Understanding adiponectin's physiology is critical for developing novel treatments for insulin resistance and fatty liver disease.
  • Further research into adiponectin modulation holds promise for metabolic disease management.